Speaker SectionNEXT AI 2026 WONJU Speaker

Colley Hwang is the Founder and Chairman of DIGITIMES and an Ambassador-at-Large for Taiwan.

With over 40 years of experience as a technology and semiconductor supply chain analyst, he offers strategic advice to global tech giants and governments across the United States, China, Japan, Korea, and Taiwan. He is the author of 10 best-selling books and a two-time Golden Book Award winner.

A globally renowned speaker and scholar, he has lectured at prestigious institutions including Stanford University, Harvard University, and Keio University, and delivered keynote speeches at prominent global tech conferences.

DIGITIMES Inc. is a world-leading media and research organization focused on the global ICT, semiconductor, and electronics supply chain industries.

Headquartered in Taipei, Taiwan, DIGITIMES delivers daily real-time reporting, in-depth supply chain analysis, and strategic market intelligence through DIGITIMES Research to technology leaders, investors, and policymakers worldwide.

By providing authoritative coverage spanning AI, mobility, components, and regional ecosystems, DIGITIMES serves as the essential strategic intelligence bridge connecting Asia's manufacturing powerhouses with the global technology industry.

(Official Website: https://www.digitimes.com/)

Herman Wu is a Principal Instructor and Senior Training Lead at the NVIDIA Deep Learning Institute (DLI). Specializing in Agentic AI and Physical AI, he works closely with industry, academia, and partners across Asia to drive AI skills development through NVIDIA's training, certification, and instructor programs.

Founded in 1993, NVIDIA is the world leader in accelerated computing and AI. Today, NVIDIA is a full-stack AI infrastructure company powering the world’s AI factories.

Henry Hu, Ph.D. is a Sales Director at Supermicro, focusing on AI computing infrastructure, GPU server solutions, and next-generation data center development. He works closely with customers and ecosystem partners on large-scale AI infrastructure projects, covering GPU computing, rack-scale integration, liquid cooling, and data center solutions across the Asia-Pacific region.

He holds a Ph.D. in Mechanical Engineering and has extensive experience in business development, product development, and thermal management technologies, including both air-cooling and liquid-cooling architectures.

Prior to joining Supermicro, he served as Associate Director of Global Business Development at ADLINK Technology, responsible for global business development and industry solution expansion.

With over 20 years of industry experience, Henry brings together business development, computing infrastructure, and thermal engineering expertise to support scalable and energy-efficient AI infrastructure deployment.

Supermicro is a global leader in high-performance, high-efficiency server technology and comprehensive data center solutions. Founded in Silicon Valley in 1993, the company designs and delivers end-to-end infrastructure optimized for Artificial Intelligence (AI), Cloud Computing, High-Performance Computing (HPC), 5G, and Edge Computing.

Leveraging its proprietary Building Block Solutions® architecture, Supermicro rapidly delivers custom-configured systems tailored to diverse workload demands. Today, the company is at the forefront of green computing and next-generation liquid cooling technologies, driving high density, energy efficiency, and sustainability for modern AI data centers worldwide.

Dr. Robert Zarnetta is an industrial quality management and precision measurement expert at ZEISS Industrial Quality Solutions, overseeing global customer strategies across major industries including automotive and electric vehicles, electronics, medical, aerospace, and energy. ZEISS provides precision measurement, microscopy, 3D scanning, industrial CT, and X-ray inspection solutions to more than 20,000 industrial customers worldwide, and he connects industry-specific requirements with technology, product, and market strategies.

He holds a doctorate in engineering in the field of materials science. After working as a researcher and postdoctoral researcher at Ruhr University Bochum in Germany, he joined ZEISS after working at the global strategy consulting firm Roland Berger. He subsequently led the industrial microscopy applications business and the manufacturing and assembly industry segment, and has served as Head of the Industrial Microscopy Solutions business unit since 2021.

His expertise includes non-destructive testing using high-resolution 3D X-ray microscopy and industrial CT, internal defect analysis of batteries and advanced components, precision dimensional measurement, and automated quality management. More recently, he has been driving ZEISS's global industrial customer strategy with a focus on inspection automation using AI and machine learning and data-driven manufacturing quality innovation. ZEISS has also developed machine-learning-based automated particle classification technology for industrial applications to improve inspection efficiency and reproducibility.

ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. For its customers, ZEISS develops, produces, and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery.

With a portfolio aligned with future growth areas like digitalization, healthcare, and Smart Production, and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. With over 46,000 employees, ZEISS is active globally in almost 50 countries. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.

Kenneth Tai is a prominent tech investor, entrepreneur, and AI infrastructure strategist who has played a vital role in the advancement of Taiwan's technology industry.In 1976, he co-founded Acer and later served as an early angel investor in ASUS, helping lay the growth foundation for Taiwan's two flagship PC brands. Leveraging his extensive experience in Silicon Valley, he founded InveStar Capital in 1996. With TSMC participating as a strategic Limited Partner (LP), the fund achieved an Internal Rate of Return (IRR) of around 50% and invested in trailblazing global semiconductor leaders, including Marvell, MPS, Atheros, and Richtek.He also co-founded DIGITIMES alongside Morris Chang (Founder of TSMC), Stan Shih (Founder of Acer), and Matthew Miau (Chairman of MiTAC-SYNNEX Group). During his tenure as Chairman of Chief Telecom, he spearheaded the development of carrier-grade data centers well before cloud computing entered the mainstream, establishing an early foundation for digital infrastructure. In 2023, he founded Zettabyte, aiming to build independent, sovereign AI infrastructure powered by Taiwan's own hardware, data, and networks and operated by local talent—ensuring Taiwan commands its own AI future.

Headquartered in Taipei with an office in Palo Alto, California, Zettabyte is an AI computing infrastructure company that builds the cloud platforms and software infrastructure required to operate AI data centers.

With "AI Sovereignty" at its core, Zettabyte empowers governments and enterprises to independently build and operate their own AI computing infrastructure through its Build-Operate-Train & Transfer (BOTT) model. The company supports the entire lifecycle—from data center design and operation to local workforce training and the eventual transfer of operational control and ownership. Its vendor-neutral architecture minimizes dependency on specific suppliers and prevents technological lock-in.

Through its proprietary cloud platform, zCLOUD, Zettabyte flexibly provides the computing resources required for AI training and inference. It champions "Quality Compute"—managing the practical performance and value of AI infrastructure based on reliability, availability, cost transparency, and energy efficiency.

Currently, Zettabyte operates across Taiwan, Japan, Southeast Asia, and the United States.

Jerry Liang is the President of Leadtek Research Inc., a Taiwan-based technology company and long-standing NVIDIA partner with extensive expertise in GPU computing, AI infrastructure, high-performance computing (HPC), and enterprise AI solutions.

He holds an MBA from the University of Dubuque. Jerry leads Leadtek’s corporate strategy, global business development, and AI transformation, steering the company’s expansion from GPU hardware solutions into comprehensive AI infrastructure and enterprise platforms.

He is also actively driving Leadtek’s international growth, prioritizing Korea as a strategic hub for advanced AI and computing deployment.

Founded in 1986, Leadtek Research Inc. is a world-renowned technology provider specializing in GPU computing, high-performance visualization, and enterprise AI infrastructure.

As an Elite Partner of NVIDIA, Leadtek designs and delivers advanced NVIDIA RTX solutions, AI workstations, high-density GPU servers, and data center platforms globally. Expanding beyond hardware manufacturing, Leadtek actively integrates AI algorithms and software ecosystems to deliver smart healthcare, smart manufacturing, and digital twin solutions to global enterprise clients.

(Official Website: https://www.leadtek.com/)

Dr. Allen Lien is the Chairman of Acer Medical, bringing a unique blend of medical expertise, public health leadership, and technological vision to the industry.

He holds a Doctor of Public Health (DrPH) from Harvard University and has a distinguished career spanning clinical practice, international diplomacy, and epidemic prevention.

At Acer Medical, Dr. Lien leads the mission to unlock the healthcare industry's full potential by breaking barriers between technology and medicine.

He oversees the development of "Intelligence in Practice," leveraging AI and clinical data to empower practitioners, enhance procedural efficiency, and enable early disease detection. Under his leadership, Acer Medical orchestrates the entire value chain—from research to global implementation—ensuring that human-centric, intelligent healthcare solutions are accessible to all.

Acer Medical helps unlock the healthcare industry's full potential by breaking barriers between technology and medicine to achieve real-world impact.

We leverage artificial intelligence, rich clinical data, and software development capabilities to empower practitioners with actionable insights—what we coin "Intelligence in Practice". This helps solve resource shortages and process inefficiencies while enabling early disease detection.

As a subsidiary of the Acer Group, Acer Medical connects partners across the entire medical care value chain—from clinical research and product development to implementation and expert support.

Our innovations are certified by international authoritative bodies, including ISO 13485 and the TFDA. We continue to explore critical research with our partners to ensure intelligent, human-centric medical care is accessible for all.

(Official Website: https://www.acer-medical.com/ch/)

Ondřej Fišer, Ph.D., is an Associate Professor at the Czech Technical University in Prague (CTU) and co-founder of Tonagena, a university spin-off translating biomedical engineering research into commercial technologies.

His research focuses on biomedical electromagnetics, electroporation, numerical modelling, and the development of technologies for advanced biomedical applications. His work spans the translational pathway from computational modelling and experimental research to prototype development, validation, and commercialization. He has extensive experience in multidisciplinary research at the interface of engineering, biology, and medicine, collaborating with universities, hospitals, and research institutions across Europe.

Alongside his academic career, he is actively involved in technology transfer and entrepreneurship. At Tonagena, he focuses on translating electroporation research into practical technologies for controlled and reproducible electroporation, with applications ranging from biomedical research and gene delivery to future gene therapy, cancer treatment, and cardiac applications.

Tonagena is a technology spin-off of the Czech Technical University in Prague (CTU), developing advanced research technologies for groups working in gene therapy and cardiac electrophysiology.

The company develops electroporation solutions for controlled, reproducible, and data-driven biomedical research. Its core platform includes TonaPulse®, a CE-certified precision pulse generator providing flexible control of electroporation parameters, and TonaWell, a reusable electrode platform designed for reproducible electroporation of adherent cell cultures and organoids.

Tonagena is particularly focused on electroporation for gene delivery and gene therapy research, while the underlying technology is also relevant to cancer treatment and cardiac applications. Building on its current hardware platform, the company is developing an integrated approach combining pulse generation, measurement, numerical modelling, experimental data, protocol optimization, and intelligent decision support.

Through collaboration with universities, hospitals, and research institutions, Tonagena aims to bridge the gap between academic research, reproducible experimentation, and next-generation therapies.

Official Website: www.tonagena.com

Xiaodong Tao, Ph.D., is the CEO of Xunfei Healthcare Technology Co., Ltd. and a renowned expert in medical artificial intelligence and imaging technologies.

He graduated from the University of Science and Technology of China (USTC) with a B.S. degree in Electrical Engineering and Information Science, and earned his Ph.D. in Electrical and Computer Engineering from Johns Hopkins University in 2005, specializing in medical imaging. Prior to joining Xunfei Healthcare Technology Co., Ltd., Dr. Tao built a distinguished career at General Electric (GE) and Royal Philips Electronics of the Netherlands, leading R&D teams in cutting-edge healthcare technologies spanning imaging devices, imaging methods, clinical applications, and radiology solutions.

He joined Xunfei Healthcare Technology Co., Ltd. as CEO in January 2017 to spearhead the company’s AI-driven medical innovations. Since 2021, he has also served as an adjunct professor and doctoral advisor at the School of Biomedical Engineering at the University of Science and Technology of China.

Xunfei Healthcare Technology Co., Ltd. (02506.HK), founded in 2016 and listed on the Main Board of the Hong Kong Stock Exchange in December 2024, is the first Hong Kong-listed company focused on healthcare-specific large language models (LLMs).

Powered by its proprietary iFlytek Spark Medical Large Model, the company develops healthcare AI solutions across three core pillars: AI Clinical Assistant, AI Health Assistant, and AI Digital Infrastructure.

The company is committed to advancing the commercialization and standardization of medical LLMs. Its Spark Medical Large Model continues to evolve across key applications, including medical Q&A, diagnostic assistance, medical record generation, and multimodal interaction, driving the transition of healthcare AI from standalone tools toward scalable, platform-based services. Its solutions span primary healthcare, hospitals, family health management, and regional healthcare governance, covering 31 provincial-level regions, 828 districts and counties, and over 77,000 primary healthcare institutions, alongside deployments in more than 700 accredited hospitals.

José Bueno Delgado is the Founder and CEO of Beclarus Partners Group, with twenty years in semiconductors and technology across Europe, Asia and North America.

He spent nine years at Samsung Electronics in Seoul, where he was a Director in the Memory Division and the first foreign national to lead a product marketing group. At ASML in Eindhoven he was Director of Corporate Strategy and later led EUV strategy and DUV product management. Earlier he worked at Hewlett-Packard and BCG.

Through Beclarus he advises investors and technology companies, develops European semiconductor and deep-tech projects with partners in the United States, Europe and Asia, and works with government and institutional stakeholders. He contributes to Fundación Innovación Bankinter's Future Trends Forum on semiconductors.

He is an Industrial Engineer (University of Seville) with a Master's in Finance (IEB, Madrid) and an MBA from the Tuck School of Business at Dartmouth.

Beclarus Partners Group is an independent advisory firm working with technology companies, investors and boards at the intersection of strategy and execution. It focuses on semiconductors, deep tech and advanced industries, including defence and agritech.

Engagements span board-level strategic advice, governance and capital raising, transaction support, business development and operating leadership.

The firm draws on the founder's network across the semiconductor value chain in Europe and Asia, and operates from Spain and the Netherlands.